Currently released so far... 97115 / 251,287

### Articles

Brazil Sri Lanka United Kingdom Sweden 00. Editorial United States Latin America Egypt Jordan Yemen Thailand

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05 2011/06 2011/07 2011/08
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23 2011/05/24 2011/05/25 2011/05/26 2011/05/27 2011/05/28 2011/05/29 2011/05/30 2011/05/31
2011/06/01 2011/06/02 2011/06/03 2011/06/04 2011/06/05 2011/06/06 2011/06/07 2011/06/08 2011/06/09 2011/06/10 2011/06/11 2011/06/12 2011/06/13 2011/06/14 2011/06/15 2011/06/16 2011/06/17 2011/06/18 2011/06/19 2011/06/20 2011/06/21 2011/06/22 2011/06/23 2011/06/24 2011/06/25 2011/06/26 2011/06/27 2011/06/28 2011/06/29 2011/06/30
2011/07/01 2011/07/02 2011/07/04 2011/07/05 2011/07/06 2011/07/07 2011/07/08 2011/07/10 2011/07/11 2011/07/12 2011/07/13 2011/07/14 2011/07/15 2011/07/16 2011/07/17 2011/07/18 2011/07/19 2011/07/20 2011/07/21 2011/07/22 2011/07/23 2011/07/25 2011/07/27 2011/07/28 2011/07/29 2011/07/31
2011/08/01 2011/08/02 2011/08/03 2011/08/05 2011/08/06 2011/08/07 2011/08/08 2011/08/10 2011/08/11 2011/08/12 2011/08/13 2011/08/15 2011/08/16 2011/08/17 2011/08/19 2011/08/21 2011/08/22 2011/08/23 2011/08/24 2011/08/25

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/03 1972/08
1973/04 1973/10
1975/03
1979/08
1985/01 1985/02 1985/03 1985/04 1985/05 1985/06 1985/10
1986/02 1986/05 1986/08 1986/09 1986/11 1986/12
1987/04 1987/06 1987/07 1987/09 1987/12
1988/01 1988/03 1988/04 1988/07 1988/08 1988/09 1988/10 1988/11 1988/12
1989/01 1989/03 1989/04 1989/06 1989/09 1989/11 1989/12
1990/01 1990/02 1990/03 1990/07 1990/08 1990/10 1990/11 1990/12
1991/01 1991/03 1991/05 1991/06 1991/07 1991/08 1991/09 1991/10 1991/11
1992/01 1992/03 1992/04 1992/05 1992/06 1992/07 1992/08 1992/09 1992/10 1992/11 1992/12
1993/01 1993/02 1993/04 1993/07 1993/10 1993/11 1993/12
1994/01 1994/02 1994/03 1994/04 1994/05 1994/06 1994/08 1994/11 1994/12
1995/01 1995/02 1995/03 1995/04 1995/05 1995/06 1995/07 1995/08 1995/09 1995/10 1995/11 1995/12
1996/06 1996/07 1996/08 1996/09 1996/11
1997/01 1997/02 1997/03 1997/04 1997/05 1997/06 1997/08 1997/09 1997/10 1997/11 1997/12
1998/02 1998/03 1998/05 1998/07 1998/08 1998/11 1998/12
1999/01 1999/09 1999/10 1999/11 1999/12
2000/04 2000/05 2000/06 2000/07 2000/08 2000/09 2000/10 2000/11 2000/12
2001/01 2001/02 2001/03 2001/04 2001/05 2001/06 2001/07 2001/08 2001/09 2001/10 2001/11 2001/12
2002/01 2002/02 2002/03 2002/04 2002/05 2002/06 2002/07 2002/08 2002/09 2002/10 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Antananarivo Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Alexandria Consulate Adana American Institute Taiwan, Taipei
Embasy Bonn Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Brazzaville Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangui Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Belfast Consulate Barcelona
Embassy Cotonou Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chiang Mai Consulate Chennai Consulate Chengdu Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar DIR FSINFATC Consulate Dusseldorf Consulate Durban Consulate Dubai Consulate Dhahran
Embassy Freetown Consulate Fukuoka Consulate Frankfurt
Embassy Guatemala Embassy Grenada Embassy Georgetown Embassy Gaborone Consulate Guayaquil Consulate Guangzhou Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Hong Kong Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Izmir Consulate Istanbul
Embassy Jakarta Consulate Johannesburg Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kolonia Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Krakow Consulate Kolkata Consulate Karachi Consulate Kaduna
Embassy Luxembourg Embassy Lusaka Embassy Luanda Embassy London Embassy Lome Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy Libreville Embassy La Paz Consulate Leipzig Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Mission Geneva Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Mogadishu Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maseru Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Merida Consulate Melbourne Consulate Matamoros Consulate Marseille
Embassy Nouakchott Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Nuevo Laredo Consulate Naples Consulate Naha Consulate Nagoya
Embassy Ouagadougou Embassy Ottawa Embassy Oslo Consulate Osaka Kobe
Embassy Pristina Embassy Pretoria Embassy Praia Embassy Prague Embassy Port Of Spain Embassy Port Moresby Embassy Port Louis Embassy Port Au Prince Embassy Podgorica Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Ponta Delgada Consulate Peshawar
Embassy Quito Consulate Quebec
REO Mosul REO Kirkuk REO Hillah REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Surabaya Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy Tirana Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana Consulate Thessaloniki
USUN New York USMISSION USTR GENEVA USEU Brussels US Office Almaty US Mission Geneva US Mission CD Geneva US Interests Section Havana US Delegation, Secretary US Delegation FEST TWO UNVIE UN Rome Embassy Ulaanbaatar
Embassy Vilnius Embassy Vientiane Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde Consulate Yekaterinburg
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AF ADANA ASEC AFIN AMGT AE AORC AID AR AO AU ASEAN AGOA AFGHANISTAN AFFAIRS AMED APER ASECARP APEC AEMR AS AA ANET AFLU ABLD AL ASUP AJ APECO AMER ABUD AODE AM AFSN AESC AND AG ALOW AROC AVIANFLU ATRN ACOA AEGR AMGMT AADP AFSI ACABQ APRM AZ AIDS ASE AGAO ADCO ABDALLAH ARF AIDAC ACOTA ASCH AC ASEG AGR ACS AMCHAMS AN AMIA ASIG ADPM ADB ANARCHISTS ALOWAR ARM AUC AINF AINT AORG AY AVIAN AMEDCASCKFLO AK ARSO ARABBL ASO ANTITERRORISM ARABL AOWC AGRICULTURE ALJAZEERA AMTC AFINM AOCR ABER ARR AFPK ASSEMBLY ASSK AZE AORCYM AINR AGMT AEC ACKM APRC AIN ASCC AFPREL ASED APERTH ASFC ASECTH AFSA AOMS AORCO ANTXON ARC AFAF ADIP AIAG AFARI AEMED AORL AX ASECAF AOPC ASECAFIN AFZAL APCS AMB AGUIRRE AEMRASECCASCKFLOMARRPRELPINRAMGTJMXL AIT ARCH AMEX ALI AQ ATFN AMBASSADOR AORCD AVIATION ARAS AINFCY ACBAQ AOPR AREP ALEXANDER ATRD AEIR AOIC ABLDG ASEX AFR ASCE ATRA ASEK AER ALOUNI AMCT AVERY APR AMAT AEMRS ASPA AFU AMG ATPDEA ALL AECL ACAO ASECKFRDCVISKIRFPHUMSMIGEG AORD AFL AME ADM ASECPHUM AGIT ABT ASECVE AGUILAR AT ABMC ALZUGUREN ANGEL ASR ANTONIO
BMGT BEXP BM BG BL BA BR BTA BO BY BBSR BLUE BK BF BTIO BELLVIEW BE BU BN BH BD BC BTC BILAT BT BX BRUSSELS BP BB BRPA BUSH BURMA BMENA BESP BIT BBG BGD BMEAID BAGHDAD BEN BIO BMOT BWC BLUNT BURNS BUT BGMT BAIO BCW BOEHNER BFIF BOL BASHAR BIMSTEC BOU BIDEN BZ BFIN BTRA BI BHUM BOIKO BERARDUCCI BOUCHAIB BORDER BEXPC BTIU BTT BIOS BEXB BGPGOV BOND BLR
CE CG CH CVR CASC CU CI CD CO CDG CB CJAN CPAS COM CVIS CMGT CT CENTCOM CNARC CTERR COUNTER CHIEF CDC CTR CBW COUNTRY CLEARANCE CY CA CM CS CWC CN CITES CF CWG CIVS CFIS CASCC CROATIA CONS COUNTERTERRORISM CASA COE CJ CHR CODEL CR CBC CACS CHERTOFF CAS CONTROL CONDITIONS CONDOLEEZZA CITEL CV CLINTON CHG CZ CON CTBT CEN CRIMES COMMERCE CLOK CRISTINA CFED CARC CND CTM CARICOM COUNTRYCLEARANCE CBTH CHINA CSW CICTE CJUS CYPRUS CW CAMBODIA CENSUS CIDA CRIME CBG CBE CMGMT CAIO CEC CARSON CPCTC CEDAW COMESA CVIA CWCM CEA COSI CAPC CGEN COPUOS CGOPRC COETRD CKGR CFE CQ CITT CIC CARIB CVIC CLO CAFTA CVISU CHRISTOPHER CACM CIAT CDB CIS CUL CHAO CNC CL CSEP COMMAND CENTER COL CAN CAJC CUIS CONSULAR CLMT CIA CBSA CEUDA CAC CROS CIO CPUOS CKOR CVPR CONG CONTROLS CEPTER CVISCMGTCASCKOCIASECPHUMSMIGKIRF CDCE
DPOL DEMARCHE DHS DR DA DISENGAGEMENT DEMOCRATIC DEFENSE DJ DY DARFUR DHRF DEA DTRO DPRK DO DARFR DOC DRL DK DOJ DTRA DOMESTIC DAC DOD DEAX DIEZ DEOC DELTAVIOLENCE DCOM DMINE DRC DCG DPKO DOMESTICPOLITICS DE DB DOT DEPT DOE DHLAKAMA DHSX DS DKEM DAO DCM DANIEL DEM DAVID DCRM
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
FR FREEDOM FINREF FJ FI FRELIMO FOREIGN FAA FETHI FAS FTAA FRB FAO FCS FINANCE FWS FTA FEMA FDA FLU FRANCISCO FBI FORCE FO FARC FK FT FCSC FAC FM FMGT FINV FCSCEG FARM FERNANDO FINR FIN FINE FIR FDIC FOR FOI FCUL FKLU FMLN FISO FIXED
GM GMUS GG GR GE GAZA GT GH GZ GJ GLOBAL GV GABY GOI GA GCC GB GY GATT GC GUAM GEORGE GTIP GOV GOMEZ GUTIERREZ GL GKGIC GF GU GWI GARCIA GTMO GN GANGS GIPNC GAERC GREGG GUILLERMO GASPAR GERARD GI
HK HR HUMANR HUMAN HO HA HUMANRIGHTS HU HHS HIV HUM HRKAWC HILLEN HILLARY HDP HUMRIT HSTC HUMANITARIAN HCOPIL HADLEY HURI HL HRETRD HOURANI HG HARRIET HESHAM HI HNCHR HARRY HRECON HRC HOSTAGES HEBRON HUMOR HSWG HYMPSK HECTOR HN HYDE HUD HRPGOV HIGHLIGHTS
ID ILC IS IZ ICAO IMO ITU IR IAEA ICRC IPROP IT IBRD ISRAELI IRAQI ISSUES ITRA IV IO IGAD IRAQ IN IMF ICTR ISCON IADB IDB IEA INR IWC ICCAT ILO INMARSAT IOM ICJ IQ ISPA ITRD IPR INTELSAT ISN IAHRC INTERNAL IFAD IICA IHO IRAN IL IRCE IC INTELLECTUAL IRM IE ICTY IDLI IFO ISCA INF INL ISRAEL INV IBB INFLUENZA ISPL ITER ITIA INRA ISAF IACHR INTERPOL IFR IRS INRB IEF ISAAC ICC INDO IIP IATTC INAUGURATION IND INS IZPREL IACI IEFIN INNP ILAB IA IMTS ITALY ITALIAN IFIN IRAJ IX ICG IF ITPHUM ITA IP IACW IK IUCN IZEAID IRPE IDA ISLAMISTS ITF INRO IBET IDP IRC ISO ICES IRMO ITPGOV IQNV IMSO IRDB IMET INCB IFRC
JA JO JP JM JCIC JOHN JE JEFFERY JS JUS JN JOHNNIE JAMES JKUS JOSEPH JML JAWAD JSRP JIMENEZ JOSE JKJUS JK JAPAN
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
LE LU LH LA LG LO LY LANTERN LI LABOR LORAN LTTE LT LAS LAB LAW LVPR LARREA LEBIK LAURA LS LOTT LOVE LR LEON LAVIN LGAT LV LAOS LOG LN LB
MOPS MO MARR ML MASS MZ MR MNUC MX MV MCC MY MEDIA MTCRE MG MCAP MOPPS MP MI MK MC MD MA MU MASC MW MT MEPP MN MTCR MH MEPI MIL MNUCPTEREZ MMAR MICHAEL MUNC MDC MPOS MONUC MAR MGMT MAS MEPN MENDIETA MARIA MONTENEGRO MOOPS MSG MARITIME MURRAY MUKASEY MOTO MCA MFO MEX MRSEC MMED MACP MAAR MINUSTAH MCCONNELL MAPP MGT MARQUEZ MANUEL MNUR MCCAIN MF MOHAMMAD MOHAMED MNU MFA MILITANTS MINORITIES MTS MLS MILI MIAH MEETINGS MERCOSUR MED MARAD MNVC MINURSO MNUCUN MIK MARK MBM MPP MILITARY MAPS MNUK MILA MTRRE MACEDONIA MICHEL MASSMNUC MUCN MQADHAFI MPS MARRGH MRCRE MTRE MORALES MAP MCTRE MHUC MOPSGRPARM MOROCCO MCAPS
NL NU NS NI NPT NATO NO NG NATEU NSF NZ NAS NP NDP NLD NGO NEPAD NAFTA NASA NEA NGUYEN NIH NK NIPP NONE NR NANCY NEGROPONTE NRR NERG NSSP NSG NSFO NE NATSIOS NFSO NATIONAL NTDB NT NCD NTSB NRC NELSON NAM NH NPG NEC NSC NFATC NMFS NATOIRAQ NAR NZUS NARC NCCC NA NC NEW NRG NUIN NOVO NATOPREL NEY NV NICHOLAS NPA NW NARCOTICS NORAD NOAA NON NTTC NKNNP NMNUC NUMBERING
ODIP OIIP OPRC OSCE OREP OTRA OPET OSCI OVIP OECD OCII OUALI OPDC OEXC OFPD OPIC OFDP OPCW OECV OAS OM OMIG ODAG OPREP ORA OIC OEXCSCULKPAO OIG OASS OFFICIALS ORTA OSAC OIL OIE OEXP OPEC OPDAT OMS OES OHI OMAR OCRA OFSO OCBD OSTA OAO ONA OTP ORC OAU OXEC OA ODPC OPDP OVIPPRELUNGANU OASC OSHA OPCD OTR OPPI OPCR OF OFDPQIS OSIC OHUM OSTRA OASCC OBSP OFDA OPICEAGR OIM OGAC OTA OTRAORP OPPC OESC OCEA OVP ON OPAD OTAR OCS ODC OTRD OCED OSD ORUE OREG
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS
QA QUAN QUOC QM QI QADRI QT QU
RS REFUGEES RW RP RELFREE RO REGIONAL RIGHTS REACTION REPORT RU RENAMO RIGHTSPOLMIL REFORM RM REFUGEE REL RELATIONS ROW RREL REGION RATIFICATION RBI RICE ROOD RODENAS RUIZ RODHAM ROBERT RGY ROY REUBEN RELIGIOUS RUEHZO RODRIGUEZ RUEUN RELAM RSP RF RSO RCMP REO ROSS RPTS RENE REID RUPREL RMA RI REMON RPEL RFE RFIN RA RAFAEL RAY RUS RPREL ROBERTG RECIN RAMONTEIJELO
SNAR SP SN SMIG SL SOCI SU SG SF SENV SZ SOE SCUL SY SO SR SYR SE SA SW SIPDIS SCIENCE SADC SI SCI SOCIETY SC SAARC STR SECRETARY SANC SSH ST SNA SGWI SEP SOCIS SETTLEMENTS SPECIALIST SK SHUM START STET SCVL SREF SCHUL SCUIL SYRIA SECURITY SPCE SYAI SMIL SOWGC STEPHEN SNRV SKCA SENSITIVE SECI SNAP SPP SCUD SOM SPECI SMIGBG SENC SCRM SGNV SECTOR SENVEAGREAIDTBIOECONSOCIXR SENVSXE SASIAIN SACU SENVSPL SWMN STEINBERG SOPN SOCR SCOI SCRS SILVASANDE SWE SARS SNARIZ SUDAN SENVQGR SM SNARKTFN SAAD SD SAN SIPRNET STATE SENS SUBJECT SFNV SECSTATE SSA SPCVIS SOI SOFA SCULKPAOECONTU SPTER SKSAF SENVKGHG SHI SEVN SANR SPSTATE SMITH SCOM SH SNARCS SNARN SIPRS SNARM SIPDI SCPR SNIG SELAB SULLIVAN SENVENV SECDEF SOLIC SOIC SPAS SASC SOSI SEC SEN SENVCASCEAIDID
TU TH TW TSPA TRGY TPHY TBIO TIFA TS TZ TX TSPL TT TK TC TINT TERFIN TERRORISM TIP TURKEY TI TECHNOLOGY TNGD TRSY TRAFFICKING TOPEC TPSL TP TD TR TA TIO TREATY TO THPY TECH TRADE TPSA TG TAGS TF TRAD THKSJA TVBIO TNDG TN TBIOZK TWI TV TWL TRT TWRO TSRY TTPGOV TAUSCHER TRBY TRBIO TL TPKO TIA TGRY TSPAM TREL TNAR TBI TFIN TPHYPA TWCH THOMMA THOMAS TERROR TRY TBID TPP TE THANH TJ TBKIO
UNGA USUN UN UG UNSC UK UP US UNCTAD UNVIE UNHRC USTR UNAMA UNCRIME UNESCO UV UNDP UNHCR UNCSD UNCHR UZ USAID UNEP UNO UNPUOS UY UNDC UNCITRAL UNAUS UNCND UA UNMIK USTDA USEU USDA UNICEF UR UNFICYP USNC USTRRP UNODC UNRWA UNOMIG USTRPS USAU USCC UNEF UNGAPL UNFPA UNSCE USSC UGA UEU UNMIC UNTAC UNION UNCLASSIFIED USPS UNA UMIK USOAS UNMOVIC UNFA UNAIDS UNCHC USGS UNSE UNRCR UNTERR USG UE UAE UNWRA UNCSW UNSCR UNCHS UNDESCO UNPAR UNC UB UNSCS UKXG UNGACG UNREST UNHR USPTO UNFCYP USCG UNIDROIT UNSCD UPU UNBRO UNECE USTRUWR UNCC UNESCOSCULPRELPHUMKPALCUIRXFVEKV
VM VE VT VETTING VN VZ VIS VC VTPREL VIP VTEAID VTEG VOA VA VTIZ VANG VISIT VO VENZ VAT VI VEPREL VEN
WFP WTO WHO WTRO WBG WMO WIPO WA WI WSIS WHA WCL WE WMN WEBZ WS WAR WZ WMD WW WILLIAM WEET WAEMU WM WWBG WWT WWARD WITH WMDT WTRQ WCO WEU WALTER WRTO WB WHTI WBEG WCI WEF WAKI WHOA WGC
XA XM XR XL XY XC XK XF XT XD XG XI XH XB XE XW XX XV XXX XJ XU XS XZ XQ XO XP XFNEA XTAG
YM YMOEXC YI YE YL YEH YMCS YOUSSEF YU
ZO ZI ZK ZR ZF ZU ZL ZP ZA ZIM ZANU ZJ ZM ZOELLICK ZCTU ZB ZN ZH ZT ZFR ZEALAND ZW ZXA

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 04ANKARA1157, Pharmaceuticals Update: Multinationals

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04ANKARA1157.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
04ANKARA1157 | 2004-02-27 11:34 | 2011-08-24 01:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Ankara

`

    This record is a partial extract of the original cable. The full text of the original cable is not available.

` `

    UNCLAS SECTION 01 OF 05 ANKARA 001157

    SIPDIS

    DEPT FOR EB/TPP/MTA/IPC - SWILSON/JURBAN AND EUR/SE
    DEPT PASS USTR FOR LERRION/BPECK
    DEPT PASS LIBRARY OF CONGRESS
    DEPT PASS USPTO FOR ELAINE WU
    USDOC FOR ITA/MAC/DDEFALCO

    SENSITIVE

    E.O. 12958: N/A
    TAGS: ETRD KIPR TU
    SUBJECT: Pharmaceuticals Update:  Multinationals
    Threatened by New Pricing Decree

    Ref:  Ankara 977 and previous

    Summary
    -------

    ¶1. (SBU) U.S. companies have complained that a new GOT
    pricing caps threaten the commercial viability of many
    of their product lines, and could lead them to delay or
    suspend the launch of new pharmaceuticals in Turkey.  In
    a letter to USTR, the Foreign Trade Undersecretary
    maintains that the GOT views data exclusivity as an EU
    Customs Union obligation rather than a WTO TRIPS
    requirement, and that this policy will be introduced
    with an unspecified transition period.  The GOT's
    Council of State rendered a decision limiting the
    application of "cheapest generic" reimbursement policy
    in the state pension fund.  Embassy requests guidance on
    the pricing decree, and urges Washington agencies to
    pursue sustained engagement with the GOT on intellectual
    property and other WTO issues affecting the
    pharmaceuticals sector.  End Summary.

    New Price System A Blow to Research-Based Firms
    --------------------------------------------- --

    ¶2. (U) At a February 20 briefing for the Ambassador,
    U.S. companies expressed serious concern with a February
    14 pricing decree.  The decree, which is already in
    force, limits pharmaceuticals prices in Turkey to a
    maximum of 90 percent of the average of the lowest two
    prices prevailing in a group of five European countries.
    While the measure does not appear to address any
    intellectual property issues, it may contain WTO-
    inconsistent provisions allowing higher prices for
    domestically-produced generic drugs, and does not set
    objective pricing criteria or remedy mechanisms for
    companies applying under the decree (reproduced in para
    9).

    ¶3. (U) Research-based companies had pressed for changes
    to the previous pricing system, which applied
    discriminatory price limits on imported pharmaceuticals,
    and had even suggested some forms of reference pricing.
    While the new system eliminates many of those
    provisions, research-based companies have told us that
    the new system will render sale of some medicines
    unprofitable, and could lead to delay or suspension in
    the launch of new molecules in Turkey.  AIFD, the
    Turkish research-based pharmaceuticals association, has
    written to the Prime Minister to register its concerns
    with the decree.

    ¶4. (SBU) Econoff raised U.S. company concerns with
    Hayriye Mihcak, the Health Ministry's Director General
    for Pharmaceuticals, Dilek Emil, the Treasury
    Undersecretariat's Deputy Director General for Foreign
    Investment, and Husnu Dilemre, Foreign Trade's Deputy
    Director General for Multilateral Agreements.  All
    expressed some surprise that research-based companies
    did not consider the decree an improvement over the
    previous pricing system.  Foreign Trade told us that the
    Turkish decree was modeled on Portugese and Spanish drug
    pricing systems.

    Data Exclusivity
    ----------------

    ¶5. (SBU) The GOT has not made an announcement on data
    exclusivity, though Mihcak told us that the Government
    planned to make an announcement on this by the end of
    March.  Dilemre also said that a decision on data
    exclusivity would be announced soon, but emphasized that
    Turkey viewed this as an EU Customs Union obligation
    rather than a WTO TRIPS requirement.  In a February 11
    letter to A/USTR Novelli (reproduced in para 10),
    Foreign Trade Undersecretary Tuncer Kayalar also made
    these points, but argued that Turkey would need a
    transition period for implementation.

    Legal Challenge on Reimbursement Policy
    ---------------------------------------

    ¶6. (U) In January 2004, the Council of State (Danistay)
    issued a ruling restricting application of the "cheapest
    generic" pharmaceuticals reimbursement policy for the
    GOT's pension fund.  The decision, a preliminary
    injunction, calls for the GOT to stop implementation,
    within 30 days, of "cheapest generic" reference pricing.
    However, industry sources have said that the injunction
    is likely to be overturned as the case moves through the
    courts.  The Danistay also limited reimbursement of
    generics to those which the GOT has certified as
    "bioequivalent" with the brand name molecule.  While
    research-based companies have welcomed the decision, the
    impact will be limited:  industry sources relate that
    there is now a bioequivalent generic for most original
    drugs.

    Comment/Action Request
    ----------------------

    ¶7. (SBU) Research-based industry is alarmed by the new
    pricing decree, though its concerns seem to lie more
    with the pricing formula for brand name drugs than with
    the parts of the decree (generic pricing, transparency)
    that could be WTO-inconsistent.  Embassy requests
    Washington agencies' guidance on whether to advocate for
    change in the pricing formula.

    ¶8. (SBU) As noted reftel, elevating Turkey in the
    Special 301 Watch List system, combined with sustained
    Washington engagement, is our best hope for prodding the
    GOT to action on data exclusivity and WTO-inconsistent
    practices.  We understand that Commerce A/S Lash and
    Senator Lugar plan to write to top GOT officials on
    pharmaceuticals issues.  Embassy continues to recommend
    that Washington agencies also consider dispatching an
    interagency IPR delegation to Ankara, and sending
    additional high-level correspondence on these issues,
    and particularly to rebut the GOT's position that the
    TRIPS Agreement does not require data exclusivity.

    ¶9. (U) Begin Text - AIFD Translation of GOT Pricing
    Decree:

    Decision No: 2004/6781
    It has been decided to enforce the attached "Decision
    Regarding the Pricing of Medicinal Product for Human
    Use" upon the letter dated 21/1/2004 and 003149 of the
    Ministry of Health, by the Council of Ministers on
    6/2/2004.

    Decision Regarding the Pricing of Medicinal Products for
    Human Use

    Article 1 - In accordance with "the Law no. 1262 on
    Pharmaceutical and Medicinal Products" and "the
    Fundamental Law no. 3359 on Healthcare Services", the
    Ministry of Health (the Ministry) shall determine the
    maximum prices by adopting the necessary measures that
    will be taken to ensure the affordability of medicinal
    products for human use (products).  Companies may
    request prices below the maximum price. The price
    approved by the Ministry of Health shall be in effect as
    of the date of its approval.

    Article 2 - The Ministry of Finance shall be authorized
    to investigate the suitability of these prices to the
    principles set forth in this Decision.

    Article 3- The maximum price of original products,
    excluding VAT, shall be determined as follows: 2
    reference countries with the cheapest prices of the
    product for which a price is to be determined in Turkey
    shall be selected out of 5 countries, namely France,
    Italy, Spain, Portugal and Greece in the year 2004 and
    to be deemed as suitable among the European Union (EU)
    countries by the Ministry; the retailer sale price of
    the product shall be determined by taking as basis
    maximum 90 percent of the average ex-factory price
    (sales price to the wholesalers calculated by deducting
    pharmacy and wholesaler profits from the retailer sale
    price) of these 2 reference countries and by adding the
    profit rates of wholesalers and pharmacies to be
    calculated in accordance with article 10. Should the ex-
    factory price in the country from where the product is
    imported be lower than the determined reference price,
    the profit rates of wholesalers and pharmacies shall be
    added to the price in the country from where it is
    imported.

    Article 4 - The retailer sales price of generic
    products, excluding VAT, shall be determined by taking
    as basis maximum 70 percent of the average of the ex-
    factory sales price of the original drugs of these
    products, calculated in accordance with article 3 and
    adding the profit rates of wholesalers and pharmacies.
    Yet, the maximum rate may be increased to 80 percent in
    case it is documented that locally manufactured raw
    materials have been utilized as the active ingredient of
    the drug in the production of generic products. In case
    the ex-factory sales price in the country from where the
    product is imported, results to be lower than the price
    determined for the EU countries, the profit rates of the
    wholesaler and pharmacies shall be added to the price in
    the pertinent country.

    Article 5 - The price of the products not marketed
    outside Turkey and the products not marketed by the EU
    countries shall be determined by taking into
    consideration the principles and the cost factors set
    forth in articles 3 and 4, provided it does not surpass
    the price of similar products.

    Article 6 - The ex-factory price of the products packed
    for hospitals shall be determined by taking into
    consideration the principles and the cost factors set
    forth in articles 3 and 4, provided it remains at least
    10percent below the unit prices of the original
    products.

    Article 7 - A "Price Evaluation Commission" shall be
    established and convene on a quarterly basis upon the
    participation of the representatives of the Ministry of
    Finance, the State Planning Organization and the Turkish
    Treasury under the coordination of the Ministry of
    Health, in order to submit proposals  to the Ministry of
    Health for the increase, decrease, or freezing of the
    price of medicinal products. In case of a change of more
    than 5percent in the foreign exchange rate within a
    minimum period of 30 days, the Price Evaluation
    Commission shall convene on an extraordinary basis, upon
    the invitation of the Ministry of Health to re-evaluate
    the prices of products. The secretarial services of the
    commission in question shall be executed by the Ministry
    of Health.

    A "Reimbursement Commission" shall be established and
    convene once every 6 months upon the participation of
    the representatives of the Ministry of Health, the State
    Planning Organization and the Turkish Treasury, the
    Social Insurance Institution, Emekli Sandygy and Bad-Kur
    and upon consulting the views of civil society
    organizations, under the coordination of the Ministry of
    Health, in order to submit proposals to the pertinent
    ministries. The secretarial services of the commission
    in question shall be executed by the Ministry of Health.

    Article  8 - Product manufacturers and importers shall
    be obligated to document that their products are
    original or generic. Manufacturers and importers shall
    be obligated to submit to the Ministry the ex-factory
    prices in the reference countries together with their
    requests for obtaining, increasing or decreasing a
    price. The TL equivalent of the prices determined shall
    be calculated upon the foreign exchange sales rate of
    the Central Bank of the Turkish Republic. The price
    which is deemed suitable shall be approved by the
    Ministry within 10 working days. The justification for a
    price which is not deemed suitable shall be communicated
    by the Ministry to the concerned company within 10
    working days. The pricing transaction shall be executed
    within 90 working days upon the submission of the valid
    documentation by the concerned company. This period may
    be extended by 60 working days in case of accumulation
    of applications and in periods of heavy workload. In
    case of failure of the concerned companies to submit
    their valid documents, the price determined by the
    Ministry shall be retained valid.

    Article 9 - In case of a decrease of 5percent or more in
    the price of the original product in the reference
    countries, the company manufacturing or importing the
    product shall be obligated to apply to the Ministry
    within 30 days to obtain a new price. A second degree
    withdrawal transaction shall be implemented on the
    products for it is determined by the Ministry that no
    such notification has been made and the registration
    shall be suspended for a period three times longer than
    the period in which no notification has been made,
    including 30 days. The suspension transaction shall be
    annulled by issuing the new price at the end of this
    period.

    Article 10- The wholesaler and pharmacy profit rates to
    be implemented when determining the retailer sales
    price of products in accordance with article 3 and 4,
    shall be determined in segments as follows, for both
    imported and local products:

    Out of the sales price to wholesalers/Wholesaler
    (Percent)/Pharmacy (Percent):

    Part up to/including 10 million TL: 9, 25
    Part between 10 - 50 million TL: 8, 24
    Part between 50 - 100 million TL: 7, 23
    Part between 100 - 200 million TL: 4, 16
    Part above 200 million TL: 2, 10

    The Ministry of Health shall be authorized to review
    these rates by taking into consideration the annual
    wholesale price index of chemical products of the State
    Statistics Institute of the former year and the
    allocation of the total sales of medicinal products in
    the last 3 years.

    Article 11 - Product manufacturers and importers are
    obligated to adhere to the principles set forth in this
    Decision.  Legal action within the pertinent
    legislation shall be taken against those in violation
    of these principles.

    Article 12 - The Ministry shall be authorized to issue
    notifications with regard to the implementation of this
    Decision.

    Article 13 - The Council of Ministers Decision dated
    6/2/2002, with no. 2002/4331 has been revoked.

    Temporary Article l- As of the publication date of this
    Decision, the prices of registered products shall be re-
    determined in accordance with the principles set forth
    in this Decision. The concerned companies shall apply to
    the Ministry upon having compiled the necessary
    documents in accordance with this Decision, within 45
    days as of the publication date of the Decision, in
    order to establish a basis for the determination of the
    new prices.  The registrations of the products for which
    no application is submitted within this period shall be
    suspended until the application date. The sales prices
    excluding VAT, to be determined in accordance with this
    article, shall not surpass the price in TL, excluding
    VAT, on the date of this Decision for local products,
    and the amount in TL, excluding VAT, corresponding to
    the foreign exchange sales rate of the Central Bank of
    the Turkish Republic, on the application date for the
    product for imported products.

    Temporary Article 2- The prices of imported products
    shall be re-determined ex-officio by the Ministry over
    the foreign exchange sales rate of the Central Bank of
    the Turkish Republic on the publication date of this
    Decision. The new prices shall be retained valid as of
    the approval date.

    Article 14- This Decision shall be enforced as of its
    publication date.

    Article 15- This Decision shall be executed by the
    Council of Ministers.

    End Text - AIFD Translation of GOT Pricing Decree.

    ¶10. (U) Begin Text - Foreign Trade U/S - USTR Letter

    February 11, 2004
    Ms. Catherine A. Novelli
    Assistant US-Trade Representative for
    Europe and the Mediterranean
    Dear Ms. Novelli,

    I would like to thank you for your letter dated January
    14, 2004 which has provided me with the opportunity to
    clarify the misconception about the compliance of
    Turkey's IPR legislation with the TRIPS Agreement.

    As you will recall, the WTO Members unanimously
    confirmed the consistency of Turkey's IPR legislation
    and implementations with the TRIPS Agreement at the
    TRIPS Council's meeting in Geneva on November 30, 2000.

    Besides, as referred in your letter, our authorities are
    working on a plan to introduce and implement rules and
    regulations regarding data exclusivity in
    pharmaceuticals in line with our commitments arising
    from the Customs Union with the EU.

    As you may appreciate, this plan will not only have
    negative impacts on the consumers and the current public
    health policies but on the generic industry as well.
    Therefore, the transition period turns out to be a
    necessity to offset to a certain extent the economic and
    social pressures and to avoid any further economic
    damages that would be recovered at a higher cost
    otherwise.

    On the other hand, I would like to note that my
    colleagues are doing their best to figure out an option
    that keeps the transition period as short as possible.
    At this point, supportive approaches from our trading
    partners will certainly contribute to the early
    conclusion of their studies.

    Expressing my best wishes and highest regards to you, I
    remain,

    Sincerely Yours,

    Tuncer Kayalar
    Undersecretary

    End Text Foreign Trade/USTR Letter.
    Edelman

`